Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Shield Thera (STX) Share Price

Price 6.25p on 14-07-2026 at 16:30:00
Change 0.00p 0%
Buy 6.50p
Sell 6.00p
Last Trade: Buy 2,667.00 at 6.30p
Day's Volume: 390,931
Last Close: 6.25p
Open: 6.25p
ISIN: GB00BYV81293
Day's Range 6.25p - 6.25p
52wk Range: 3.40p - 12.35p
Market Capitalisation: £66.85m
VWAP: 6.125494p
Shares in Issue: 1.07b

Shield Thera (STX) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 2,667 6.30p Ordinary
12:32:47 - 14-Jul-26
Buy* 4,698 6.30p Ordinary
11:17:22 - 14-Jul-26
Buy* 704 6.38p Ordinary
11:01:25 - 14-Jul-26
Sell* 16,508 6.10p Ordinary
09:38:19 - 14-Jul-26
Sell* 100,000 6.11p Ordinary
09:17:33 - 14-Jul-26
Sell* 2,084 6.00p SI Trade
08:29:56 - 14-Jul-26
Buy* 36 6.50p SI Trade
08:29:56 - 14-Jul-26
Buy* 31 6.50p SI Trade
08:29:56 - 14-Jul-26
Sell* 244 6.00p SI Trade
08:29:56 - 14-Jul-26
Buy* 46 6.50p SI Trade
08:29:56 - 14-Jul-26
See more Shield Thera trades

Shield Thera (STX) Share Price History

Time period:
to
Date Open High Low Close Volume
14th Jul 2026 (Tue) 6.25 6.25 6.25 6.25 390,931
13th Jul 2026 (Mon) 6.40 6.40 6.25 6.25 2,057,797
10th Jul 2026 (Fri) 6.35 6.40 6.35 6.40 140,128
9th Jul 2026 (Thu) 6.15 6.35 6.15 6.35 937,523
8th Jul 2026 (Wed) 6.10 6.20 6.10 6.20 1,215,324
7th Jul 2026 (Tue) 6.10 6.10 6.10 6.10 626,101
6th Jul 2026 (Mon) 6.00 6.15 6.00 6.10 1,117,780
3rd Jul 2026 (Fri) 6.05 6.15 6.05 6.15 817,881
2nd Jul 2026 (Thu) 6.15 6.15 5.90 6.05 2,151,913
1st Jul 2026 (Wed) 6.20 6.20 6.15 6.15 412,752
30th Jun 2026 (Tue) 6.15 6.20 6.15 6.20 217,402
29th Jun 2026 (Mon) 6.10 6.15 6.10 6.15 810,214
26th Jun 2026 (Fri) 6.10 6.10 6.10 6.10 256,945
25th Jun 2026 (Thu) 6.20 6.20 6.10 6.10 810,759
24th Jun 2026 (Wed) 6.55 6.50 6.20 6.20 1,307,545
23rd Jun 2026 (Tue) 6.55 6.55 6.55 6.55 412,998
22nd Jun 2026 (Mon) 6.50 6.55 6.50 6.55 491,618
19th Jun 2026 (Fri) 6.35 6.50 6.50 6.50 981,211
18th Jun 2026 (Thu) 6.40 6.40 6.34 6.40 479,983
17th Jun 2026 (Wed) 6.40 6.40 6.40 6.40 1,049,172
16th Jun 2026 (Tue) 6.40 6.40 6.40 6.40 331,119
15th Jun 2026 (Mon) 6.50 6.50 6.40 6.40 1,292,108
See more Shield Thera price history

Shield Thera (STX) Regulatory News

Date Source Headline
30th Jun 2026 7:52 am RNS Block Listing 6 Monthly Return
18th Jun 2026 4:20 pm RNS Results of 2026 Annual General Meeting
29th May 2026 9:11 am RNS Total Voting Rights
5th May 2026 7:00 am RNS Grant of Share Options
1st May 2026 7:00 am RNS Q1 2026 Trading Update
30th Apr 2026 7:01 am RNS Total Voting Rights
27th Apr 2026 7:00 am RNS Enrollment in Phase II Clinical Trial for ACCRUFeR
9th Apr 2026 12:30 pm RNS Audited results for year ended 31 December 2025
1st Apr 2026 9:22 am RNS-R Publication of Report, Reinforcing FDA Approval
31st Mar 2026 7:03 am RNS Total Voting Rights
See more Shield Thera regulatory news

Shield Thera (STX) Share News

EARNINGS AND TRADING: ProService Building Services lowers outlook

1st May 2026 13:53

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

LONDON MARKET MIDDAY: FTSE falls as US-Iran talks stall

1st May 2026 11:58

(Alliance News) - Stock prices in London were lower at midday on Friday, as hopes of diplomatic progress in the Middle East, and a batch of domestic data, failed to lift sentiment in holiday-thinned trade. Read More

WINNERS & LOSERS: Shield Therapeutics down on Medicaid concerns

1st May 2026 11:10

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Friday. Read More

TRADING UPDATES: Zenith Energy picks up two solar projects in Italy

27th Apr 2026 20:42

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

Shield Therapeutics expects "strong" Accrufer growth as revenue rises

9th Apr 2026 16:03

(Alliance News) - Shield Therapeutics PLC on Thursday highlighted a record performance from Accrufer, which it said helped drive a strong rise in annual sales. Read More

See more Shield Thera news
FTSE 100 Latest
Value10,529.39
Change31.10

Login to your account

Forgot Password?

Not Registered